Clinical Efficacy of Assisted Reproductive Technology Combined with Progesterone Capsules in the Treatment of Infertility Caused by Diminished Ovarian Reserve and Its Influence on Serum FSH, E
Journal
Journal of healthcare engineering
ISSN: 2040-2309
Titre abrégé: J Healthc Eng
Pays: England
ID NLM: 101528166
Informations de publication
Date de publication:
2022
2022
Historique:
received:
16
02
2022
revised:
28
02
2022
accepted:
07
03
2022
entrez:
4
4
2022
pubmed:
5
4
2022
medline:
6
4
2022
Statut:
epublish
Résumé
To explore the clinical efficacy of assisted reproductive technology (ART) combined with progesterone capsules in the treatment of infertility caused by the diminished ovarian reserve (DOR) and its influence on serum FSH, E2, and LH levels of patients. In the manner of retrospective study, the data of 120 patients with infertility caused by DOR admitted to our hospital (February 2019-February 2020) were retrospectively analyzed, and the patients were equally divided into the experimental group and the control group according to the order of admission. All patients underwent in vitro fertilization and embryo transfer (IVF-ET), and the experimental group was received progesterone capsules at the same time. Ovarian-related indexes, follicular development, serum hormone levels, and pregnancy outcomes were compared between both groups. After treatment, compared with the control group, ovarian-related indexes and follicular development in the experimental group were conspicuously better ( ART combined with progesterone capsules can improve serum hormone levels, ovarian function, follicular development, and clinical pregnancy rate for patients with infertility caused by DOR, which should be applied in practice.
Identifiants
pubmed: 35368963
doi: 10.1155/2022/5319172
pmc: PMC8970857
doi:
Substances chimiques
Capsules
0
Progesterone
4G7DS2Q64Y
Follicle Stimulating Hormone
9002-68-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Retracted Publication
Langues
eng
Sous-ensembles de citation
IM
Pagination
5319172Commentaires et corrections
Type : RetractionIn
Informations de copyright
Copyright © 2022 Lingqin Chen et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Curr Opin Obstet Gynecol. 2019 Jun;31(3):139-147
pubmed: 30870184
Front Endocrinol (Lausanne). 2018 Dec 21;9:772
pubmed: 30622513
Front Endocrinol (Lausanne). 2019 Jul 16;10:458
pubmed: 31379738
Arch Gynecol Obstet. 2021 Jun;303(6):1607-1616
pubmed: 33389112
Acta Obstet Gynecol Scand. 2018 Sep;97(9):1105-1113
pubmed: 29476703
FASEB J. 2019 Jun;33(6):7758-7766
pubmed: 30888848
J Clin Oncol. 2021 Jun 20;39(18):2016-2024
pubmed: 33891474
Eur Radiol. 2021 Jan;31(1):543-548
pubmed: 32770376
Horm Metab Res. 2018 Jul;50(7):537-542
pubmed: 29991084
Clin Exp Reprod Med. 2020 Dec;47(4):306-311
pubmed: 33227187
Reprod Biol Endocrinol. 2018 Mar 27;16(1):29
pubmed: 29587861
J Assist Reprod Genet. 2020 May;37(5):1097-1103
pubmed: 32285295
Fertil Steril. 2020 Dec;114(6):1174
pubmed: 33041052
Hum Reprod Update. 2020 Nov 1;26(6):904-928
pubmed: 32514566
Thyroid. 2020 Apr;30(4):580-587
pubmed: 31928168
BMJ Open. 2018 Nov 8;8(11):e023124
pubmed: 30413508
Fertil Steril. 2020 Apr;113(4):788-796.e4
pubmed: 32147173
Curr Opin Obstet Gynecol. 2018 Aug;30(4):223-228
pubmed: 29847457
Fertil Steril. 2018 Mar;109(3):446-447
pubmed: 29566860
Clin Exp Reprod Med. 2018 Mar;45(1):31-37
pubmed: 29662823